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Abstract
Background: Mammalian GIB-PLA2 are well characterized. In contrast, much less is known about aquatic ones. The
aquatic world contains a wide variety of living species and, hence represents a great potential for discovering new
lipolytic enzymes. The aim of this study was to check some biochemical and structural properties of a marine
stingray phospholipase A2 (SPLA2).
Results: The effect of some proteolytic enzymes on SPLA2 was checked. Chymotrypsin and trypsin were able to
hydrolyze SPLA2 in different ways. In both cases, only N-terminal fragments were accumulated during the hydrolysis,
whereas no C-terminal fragment was obtained in either case. Tryptic and chymotryptic attack generated 13 kDa and 12
kDa forms of SPLA2, respectively. Interestingly, the SPLA2 13 kDa form was inactive, whereas the SPLA2 12 kDa form
conserved almost its full phospholipase activity. In the absence of bile slats both native and 12kDa SPLA2 failed to
catalyse the hydrolysis of PC emulsion. When bile salts were pre-incubated with the substrate, the native kinetic protein
remained linear for more than 25 min, whereas the 12 kDa form activity was found to decrease rapidly. Furthermore,
The SPLA2 activity was dependent on Ca
2+;o t h e rc a t i o n s( M g
2+,M n
2+,C d
2+ and Zn
2+) reduced the enzymatic activity
notably, suggesting that the arrangement of the catalytic site presents an exclusive structure for Ca
2+.
Conclusions: Although marine and mammal pancreatic PLA2 share a high amino acid sequence homology,
polyclonal antibodies directed against SPLA2 failed to recognize mammal PLA2 like the dromedary pancreatic one.
Further investigations are needed to identify key residues involved in substrate recognition responsible for
biochemical differences between the 2 classes of phospholipases.
1. Introduction
Phopholipases A2 (PLA2s) are esterases that catalyse the
hydrolysis of acyl groups at the sn-2 position of glycero-
phospholipids (PL) and produce free fatty acids, such as
arachidonic acid, and lyso-PL by an interfacial activation
catalytic mechanism [1].
A large number of distinct PLA2s have been charac-
terized and classified into the broad categories of intra-
cellular and secreted forms of the enzyme. Intracellular
(cytosolic) PLA2s participate in cellular eicosanoid
metabolism and signal transduction. Numerous isoforms
of secretory phospholipases (sPLA2s) have been identi-
fied and divided into several groups, based on their
amino acid sequences, structures, catalytic mechanisms,
tissue distributions and evolutionary relationships [1,2].
Ten human secreted PLA2s have been cloned: group
(G) IB, GIIA, GIID, GIIE, GIIF, GIII, GV, GX, and
GXIIA PLA2s and the GXII PLA2-like protein that is
devoid of catalytic activity [3] and [4]. sPLA2s are low
molecular weight enzymes (14 kDa) and are abundant
in various mammalian tissues and fluids. These enzymes
are involved in various normal and pathological cell
functions [1]. A Group IB enzyme was first found in
mammalian pancreatic exudates, and therefore is known
as pancreatic PLA2. The main physiologic function of
GIB PLA2 is to digest dietary phospholipids. GIB PLA2
is synthesized in pancreatic acinar cells and secreted
into the duodenal lumen as an enzymatically inactive
PLA2 that is activated by cleavage of a 7-amino acid
activation peptide by trypsin [5].
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venoms have been used as diagnostic biochemical
reagents. In fact snake venom sPLA2sw e r ee m p l o y e dt o
analyse the position of fatty acids in phospholipids from
guina pig and pic cardiac membranes [6]. Moreover,
porcine PLA2 (PPLA2) was used in the examination of
the structural and functional changes of egg yolk low
density lipoproteins (LDL) by modifying its phospholi-
pids [7]. In addition, PPLA2 was used in industrial pro-
cesses in the food industry to produce lyso PC which is
an excellent emulsifier for food [8]. The biology and the
biochemistry of mammalian and venom PLA2 are well
documented. In contrast, few studies were reported on
the enzymology and application of PLA2 from marine
organisms [9]. Therefore, little information is available
on marine gastropod mollusc’s sPLA2 [10-16]. To date,
few studies exist on phospholipase from the digestive
gland of marine organisms. Recently, we have purified
s t i n g r a yP L A 2( S P L A 2 )f r o mt h ec o m m o ns t i n g r a y
Dasyatis pastinaca and some of its catalytic properties
were determined [17]. High similarity was found
between the N-terminal amino acid residues of SPLA2
and those of other known pancreatic PLA2. In the pre-
sence of organic solvents, as well as in acidic and alka-
line pH and at high temperature, SPLA2 stability makes
it a good candidate for its application in food industry.
It seems therefore of interest to check some other cata-
lytic and structural properties of SPLA2 to gain more
insights into their action mode on phospholipids. We
have therefore performed the limited proteolysis experi-
ments on SPLA2, using trypsin and chymotrypsin. Pro-
files regarding proteolysis and activity are reported.
2. Material and methods
2.1. Proteins
SPLA2 and DrPLA2 were purified as described by Ben
Bacha et al., [17,18]. Protein concentration was deter-
mined as described by Bradford et al. [19] using BSA (E
= 6.7) as reference.
2.2. Determination of phospholipase activity
The stingray PLA2 activity was measured titrimetrically
at pH 8.5 and at 40°C with a pH-stat, under the opti-
mum conditions, using purified egg phosphatidylcholine
(PC), phosphatidylserine (PS) or phosphatidylethanola-
mine (PE) emulsions as substrate in the presence of 4
mM NaTDC and 8 mM CaCl2 [20]. One unit of phos-
pholipase activity was defined as 1 μmole of fatty acid
liberated under standard conditions.
2.3. Limited proteolysis
S P L A 2( 1m g )w a sd i s s o l v e di n1m lo f5 0m MT r i s - H C l
buffer, pH 8.5 without benzamidine. The PLA2 solution
was digested at 4, 30 and 37°C with the selected
endopeptidase. The endopeptidase/PLA2 molar ratio var-
ied from 0.01 to 0.1. Samples (50 μl) were withdrawn from
the incubation mixture at various times to assess the resi-
dual activity and the electrophoretic profile. The reaction
was stopped by addition of benzamidine (4 mM final
concentration).
2.4. Analytical methods
Analytical polyacrylamide gel electrophoresis of proteins
in the presence of sodium dodecyl sulfate (SDS-PAGE)
was performed by the method of Laemmli [21]. Samples
for sequencing or immunoblotting were electrotrans-
ferred onto polyvinylidene difluorid and a nitrocellulose
membrane respectively [22]. Protein transfer was per-
formed during 2 h at 4 mA/cm
2 at room temperature.
2.5. Amino acid sequencing
The N-terminal sequence was determined by automated
Edman’s degradation, using an Applied Biosystems Pro-
tein Sequencer Procise 492 equipped with 140 C HPLC
system [23].
2.6. Production of polyclonal antibodies
Polyclonal antibodies directed against purified SPLA2
were produced on rabbits after subcutaneous and intra-
muscular injections every 3 weeks of 0.5 mg of pure
SPLA2. The first injection included complete Freund’s
adjuvant, while the last two injections contained incom-
plete adjuvant.
2.7. Immunoblotting technique
The reactivity of anti-SPLA2 serum with PLA2 (SPLA2
or DrPLA2) was checked using immunoblotting techni-
que. After protein transfer, membranes were rinsed
three times with PBS (phosphate buffer saline: 10 mM
phosphate pH 7.2, 150 mM NaCl), then saturated with
3% of milk powder in PBS (saturating buffer) for 1 h at
room temperature. Thereafter, anti-SPLA2 serum
diluted at 1:1000 with PBS containing 0.05% Tween-20
(PBS/Tween-20) were incubated with the membranes
for 1 h at room temperature. Afterwards, membranes
were washed three times with PBS/Tween-20 then incu-
bated for 1 h at room temperature with a 1:2000 dilu-
tion of alkaline phosphatase-conjugated anti-rabbit
immunoglobulin (Sigma). After washing, as mentioned
above, membranes were incubated with a phosphatase
substrate solution containing 0.3 mg/ml of nitroblue tet-
razolium chloride (Sigma), 0.2 mg/ml of 5-bromo-4-
chloro-3 indolyl-phosphate (Sigma) and 0.2 mg/ml of
MgCl2 to reveal the specific immunoreactivity.
2.8. Enzyme linked immunosorbent assay (ELISA) analysis
The immunoreactivity of anti-SPLA2 polyclonal antibo-
dies with phospholipases (SPLA2 or DrPLA2) was
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pases (SPLA2 or DrPLA2) were diluted using coating
buffer (PBS) to obtain a final concentration of 1 μg/ml.
Aliquots (100 μl) were coated onto polyvinyl chloride
microtiter wells and incubated overnight at 4°C. The
wells were then saturated by adding 100 μlo fs a t u r a t i n g
buffer (3% of powder milk in PBS) for 2 h at 37°C.
Thereafter, 100 μl of serum, diluted at 1:500 with satur-
ating buffer, were added to each well and the plates
were incubated for 1 h at 37°C. Afterwards, 100 μlo f
peroxidase-conjugated anti-rabbit immunoglobulin
(Sigma) diluted at 1:2000 with saturating buffer were
added to each well and the plates were kept at 37°C for
an additional hour. Then, 100 μl of freshly prepared per-
oxidase substrate solution (an o-phenylenediamine tablet
(Sigma) was solubilized in 50 mM sodium phosphate/
citrate, pH 5 containing 0.4% of fresh hydrogen perox-
ide) were added to each well. The plates were incubated
in the dark for 30 min at room temperature. The enzy-
matic reaction was then stopped by adding 50 μlo f0 . 5
MH 2SO4. The absorbance was read at 490 nm in a
micro-ELISA reader (Dynatech).
3. Results and discussion
3.1. Level of expression of SPLA2 activity
In order to compare the level of stingray PLA2 activity
with other species, the rate of hydrolysis of PC emulsion
by dromedary, bovine, chicken, and turkey pancreases
were measured under the same conditions. Results
reported in Table 1 show that the pancreases tested
secreted various levels of PLA2 activity. The highest
level was observed with turkey (200 U/g). Sheep pre-
sented only 10 U/g in its pancreas.
3.2. Annual distribution of the SPLA2 activity levels
Dasyatis pastinaca used in this study were collected
every month between January and December and the
SPLA2 activity was observed monthly. As we can see
from Figure 1, no significant difference in the PLA2
activity was observed in the monthly collected samples.
A slight increase in phospholipase activity was measured
d u r i n gt h es u m m e r( M a yt oJ u l y ) .T h i si n c r e a s ec a nb e
related to the reproduction activity during this period
and to the increase of the temperature of the sea water.
Then, Ismen (2003) [24], indicated that this species pre-
sented a high reproduction activity from May to Sep-
tember. Moreover, Spawning occurred mainly from May
to September, apparently triggered by the rising sea-
water temperature during summer.
3.3. Effect of metal ions on SPLA2 activity
The SPLA2 showed a strict dependence on calcium ions
(8 mM) for full activity using PC as substrate. The addi-
tion of Mg
2+,M n
2+,C d
2+ and Zn
2+ (10 mM) in the
absence or presence of low Ca
2+ concentration (1 mM)
significantly decreased the enzyme activity (Table 2).
The obtained data showed that substitution of Ca
2+ by
other divalent ions (Mg
2+,M n
2+,C d
2+,Z n
2+)w e r en o t
able to keep the substrate bound to the enzyme, only
Ca
2+ supported the catalytic activity (Table 2). This can
be explained by different coordination geometries
assumed by the tetrahedral intermediate due to the pre-
sence of the Ca
2+ ion which not only determines the
electrophilic behavior of the catalytic site, but also stabi-
lizes the otherwise flexible Ca
2+-binding loop and
appears to optimize the local protein conformation for
substrate interactions [25,26]. Other metals fail to pro-
ductively bind to the enzyme, competitively inhibit Ca
2
+- m e d i a t e da c t i v i t y ,o rp r o v et ob ew e a k l ya c t i v e[ 2 7 ] .
Table 1 Pancreatic PLA2 levels in some animals
Species PLA2 activity
(U/g fresh pancreas)
References
Stingray 55 ± 5 Present study
Dromedary 20 ± 3.5 [18]
Turkey 200 ± 20 [18]
Bovine 110 ± 17 [18]
Chicken 70 ± 25 [18]
Sheep 10 ± 5 [18]
The determination of the phospholipase content of pancreases from all
species was performed in a homogenate prepared in a Waring Blendor (2 ×
30 s) with 10 ml, per gram of fresh tissue, of 10 mM Tris-HCl, 150 mM NaCl,
and pH 8.5 at room temperature. After centrifugation at 12.000 rpm during 20
min, the amount of enzyme was estimated on an aliquot of the supernatant
using PC emulsion as substrate in the presence of 4 mM NaTDC and 8 mM
CaCl2. The phospholipase activity was measured titrimetrically at pH 8.0 and
at 37°C using a pH-stat. One phospholipase unit corresponds to one μmole of
fatty acid released per min using PC emulsion as substrate in the presence of
4 mM NaTDC and 8 mM CaCl2. For each species, the activity represents the
average ± standard error mean of five assays obtained from three different
pancreases.
 
 
 
 
 
 
 
Figure 1 Phospholipase activity levels found in fresh stangray
pancreas during one year. Activity was measured in optimal
conditions using PC as substrate and expressed as the number of
units per corporal weight. The bars indicate the standard error of
the means of three experiments.
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2+ and Mn
2+ in presence of low Ca
2+
concentrations support a significant catalytic activity.
3.4. Immunochemical properties
The supernatant of the stingray pancreas homogenate
containing 200 μg of total proteins was subjected to
SDS-PAGE analyses followed by immunoblotting using
anti-SPLA2 serum. Our results showed that anti- SPLA2
serum reacted with a single band (14 kDa) correspond-
ing to the SPLA2 present in the crude extract (Figure
2A, lane 1). No other protein bands were recognized by
this serum. This result suggests a good specificity of this
serum toward SPLA2. Anti-SPLA2 serum was used to
carry out cross-reactivities between SPLA2 and DrPLA2
using the ELISA and the Western blotting techniques.
SPLA2 was strongly recognized by anti- SPLA2 serum
and no cross-immunoreactivity was detected with
DrPLA2 (Figure 2A, lanes 1 and 2). For the ELISA tech-
nique used for the sake of better sensibility, microtitra-
tion plates were coated with a fixed amount of pure
SPLA2 and incubated with an antiserum diluted 100
times. Only SPLA2 reacted strongly with its correspond-
ing antiserum (Figure 2B). Figure 2C shows the effect of
the anti-SPLA2 antibody on the activities of SPLA2 and
DrPLA2. In this experiment, we used an identical PLA2
concentration. The inhibition pattern for marine PLA2
was different from that of mammal one. The anti-
SPLA2 antibody, which almost completely inhibited the
SPLA2 activity at 0.1 mg/ml, had no effect on the dro-
medary enzyme. These results might be explained by
the fact that SPLA2 may not share common antigenic
determinants with classical pancreatic PLA2. Although
the 20 residues of SPLA2-NH2-terminal end showed
significant homology with those of pancreatic PLA2, the
absence of immunoreactivity between DrPLA2 and anti-
SPLA2 serum strengthens the idea that SPLA2 could be
structurally different from mammalian pancreatic PLA2.
This hypothesis needs further structural and biochem-
ical investigations.
3.5. Cleavage of SPLA2
The SPLA2 incubation with trypsin at 30°C and using
a protease/PLA2 molar ratio of 0.05 generated three
m a j o rf r a g m e n t s :T 1( 1 3k D a ) ,T 2( 8k D a ) ,T 3( 5k D a )
and T4 (4 kDa) with a decrease of PLA2 activity by
half within 4 h (Figure 3A and 3B). These fragments
were transferred on a PVDF membrane and their N-
terminal amino acid was sequenced. The results are
given in table 3 together with the corresponding
sequences from the PPLA2. The N-terminal sequen-
cing showed that the larger 13 kDa fragment (T1) cor-
responded to an N-terminal truncated form of SPLA2
starting at residue C11. This N-terminal truncated
Table 2 Effects of different metal ions on the activity of
stingray PLA2
Ions PLA2 Activity (%)
0m MC a
2+ 1m MC a
2+
Mg
2+ 3.5 ± 1.1 60 ± 5.4
Mn
2+ 2 ± 1 57 ± 2.2
Zn
2+ 3 ± 0.5 15 ± 2.4
Cd
2+ 2 ± 0.8 12 ± 1.8
Influence of ions concentrations (10 mM each) on SPLA2 activity in the
absence or presence of 1 mM Ca
2+ was studied using PC emulsion as
substrate at 40°C and pH8.5. The control represents 100% of PLA2 activity at 8
mM Ca
2+ under the same condition. Values represent the mean of three
replicates.
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Figure 2 (A) Immunocross-reactivity of SPLA2 and DrPLA2 with
anti- SPLA2 serum using a simple sandwich ELISA. Each
experiment was performed by direct coating of one phospholipase
(100 ng/well) with a fixed dilution of 1:500 for the serum tested. (B)
Immunoblot analysis, SPLA2 solution (200 μg) (lane 1), pure SPLA2
(15 μg) (lane 2) and DrPLA2 (50 μg) (lane 3) using anti-SPLA2 serum
at 1:1000 dilution. (C) Effect of anti- SPLA2 antibody on PLA2
activity. SPLA2 (12 U) was incubated with various concentrations of
anti-SPLA2 in 0.1 M Tris-HC1, 0.1 M NaCl (pH 8.5) for 2 h at 20°C.
Similarly, DrPLA2, (12 U) was incubated with anti-SPLA2. After
incubation, the remaining activity of PLA2s was measured using PC
emulsion in the presence of 4 mM NaTDC and 8 mM CaCl2.
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Page 4 of 8SPLA2 form (13 kDa) was thus generated from clea-
vage by trypsin of the K10-C11 bond of SPLA2. The
T3 and T4 bands had the same N-terminal sequences
as the T1 peptide; whereas The T2 peptide started at
residue C66. Based on its molecular mass (7 kDa), this
band would correspond to the SPLA2 (14 kDa) lacking
N-terminal 65 amino acids. These results suggested
that SPLA2 possessed basic residue at position 65 cor-
responding to R amino acid for PPLA2 and allowing
t h et r y p t i cc l e a v a g et oo c c u r .
Our results showed that the deletion of the N-term-
inal fragment of SPLA2 (residue A1 to K10) resulted in
a loss of the enzyme activity and, thus, provided evi-
dence that the N-terminal fragment was a crucial struc-
tural domain necessary for the activity of the enzymes.
These findings collaboratew i t hp r e v i o u sf i n d i n g s
demonstrating that Helix 1 at the N-terminal of human
group 1B PLA2 (hG1B) play an important role in
enzyme function. An engineered hG1B lacking the N-
terminal helix 1 bound to membranes with weaker affi-
nity exhibited ~100-fold lower enzymatic activity com-
pared with that of the full-length hG1B. It is inferred
that this helix 1 facilitates the membrane binding, thus
enhances the enzymatic activity based on polarized
infrared spectroscopic experiments [28]. Experiments
using semi-synthetic hG1B demonstrated that helix 1
residues act as a regulatory domain and mediate interfa-
cial activation [29].
Conversely, when incubated with chymotrypsin under
the same conditions as described above, the protein
band corresponding to the native SPLA2 disappeared
within 24 h; whereas 2 major bands (C1, and C2) of dif-
ferent sizes, of about 12, and 7 kDa were accumulated
(Figure 4B). The N-terminal sequence of the C1 frag-
ment was the same as the native PLA2. This shows that
t h i s1 2k D af r a g m e n ti st h u si s s u e df r o maC - t e r m i n a l
truncation of the SPLA-2. The sequencing of the 7kDa
fragment showed that it was generated upon cleavage by
chymotrypsin of the Y25-G26 bond of SPLA2. Interest-
ingly, the chymotryptic cleavage was not accompanied
by any loss of the PLA2 activity assayed on PC emul-
sion. Furthermore, no C-terminal fragment was detected
after proteolysis. The N-terminal C1 fragment alone
seemed therefore to be active, despite the absence of the
C-terminal fragment.
The 12-kDa form was further purified by filtration on
Bio-sil SEC-125 HPLC gel filtration column (300 × 7.8
mm) equilibrated with phosphate 0.1 M buffer pH 7.0
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Figure 3 (A): Remaining activity of SPLA2 incubated with
trypsin and chymotrypsin. SPLA2 was incubated with
chymotrypsin or trypsin at 30°C (20:1 w/w) as described in Material
and methods section. The remaining activity of SPLA2 cleaved by
chymotrypsin and by trypsin towards PC emulsion in the presence
of 4 mM NaTDC and 8 mM CaCl2 was measured at various
incubation times. Samples were withdrawn from the incubation
mixtures at various times and analysed. (B): SDS-gel electrophoresis
analysis of the tryptic cleavage of SPLA2 as a function of time. The
gel was stained with Coomassie blue to reveal proteins. Lane 1,
molecular mass markers; lane 2, SPLA2; lanes 3, after incubation of
SPLA2 with trypsin for 30 h. (C): SDS-gel electrophoresis analysis of
the chymotryptic cleavage of SPLA2 as a function of time. The gel
was stained with Coomassie blue to reveal proteins. Lane 1,
molecular mass markers; lane 2, SPLA2; lane 3, after incubation of
SPLA2 with chymotrypsin for 24 h.
Table 3 Sequences comparison of protein fragments
isolated after chymotryptic and tryptic proteolysis of
SPLA2 with PPLA2
For comparison, bold, underlined, and italic symbols of residues indicate
identical, homologous, and different amino acids, respectively. The Ca
2+ loop
(C27-G32) is bold shaded. Stars indicate the amino-acid residues of the catalytic
triad. The arrows indicate the tryptic or chymotryptic cleavage site of SPLA2.
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formed with the same buffer at 30 ml/h and SPLA2
emerged 9 min after injection (Figure 4A). The fractions
containing the PLA2 activity were pooled, and SDS⁄
PAGE analysis revealed only one band corresponding to
12 kDa SPLA2 (Figure 4B).
In order to get more new insights into the mode of
protein/substrate interaction, more kinetic behaviour of
12-kDa fragment was checked. The rate of hydrolysis of
different concentrations of PC, PE and PS were measured
under optimal conditions (4 mM NaTDC, 8 mM, CaCl2,
and pH 8.5 and 40°C). The Lineweaver-Burk curves were
plotted (data not shown). From these fits, the substrate
affinity constants (KM) and the turnover of the enzy-
matic reaction (kcat) were obtained and shown with the
deduced catalytic efficiency (kcat/KM) in Table 4. For
further comparison, we reported in the same Table 4 the
kinetic parameter values obtained with the native SPLA2,
and DrPLA2 under the same conditions.
From these values, one can say that the two marine
PLA2s, showing essentially thes a m ea c t i v i t yt o w a r da l l
the tested substrates, hydrolyse the different phospholi-
pids more efficiently than mammalian one since the
ratio representing the catalytic efficiency (Kcat/Km) is
about 1.5-2 times higher with native SPLA2 and 12 kDa
SPLA2 than with DrPLA2.
On the other hand, marine and mammalian PLA2
preferentially hydrolyse the phospholipids in the follow-
ing order PE > PC > PS. Only one unique feature was
noted from the activity of 12kDa SPLA2 toward various
substrates. The 12 kDa form activity was found to
decrease rapidly, in the presence of bile salts and cal-
cium (Figure 5). Under the same conditions, native
SPLA2 and DrPLA2 were able to hydrolyze efficiently
the different substrates without any denaturation and
the kinetics remained linear for more than 25 min (Fig-
ure 5). Similar results were obtained when PE or PS
were used as substrate (Data not shown).
Several studies have provided evidence that bile salts
are tensioactive agents ensuring in their micellar form,
the dispersion of the lipolytic products (of hydrolysis)
[30,31]. Along the same line, De Haas et al. reported
that micellar forms of the substrate were hydrolyzed at
a much higher rate than substrates molecularly dis-
persed by PLA2 [32]. As previously reported SPLA2 and
DrPLA2 failed to catalyze the hydrolysis of pure PC. To
trigger the PLA2 activity on PC, NaTDC was added
prior to the enzyme injection [17,18]. In its presence,
the kinetics remained linear for more than 25 min (Fig-
ure 5). Similar result was obtained with 12 kDa SPLA2
(data not shown), whereas, the pancreatic chicken PLA2
(ChPLA2) was found to hydrolyze efficiently PC in the
absence of NaTDC and its maximum specific activity
was found to be nearly independent of NATDC [33].
This difference between SPLA2, DrPLA2 and ChPLA2
might be explained by structural variation of exposed
residues between the different phospholipases.
Previous work reported that the overall structural and
functional perturbations caused by deleting nine C-termi-
nus residues of bovine pancreatic PLA2 over expressed in
Escherichia coli were modest, but the C-terminus deletion
mutant displayed an interesting and significant property. It
 
 
Figure 4 Filtration on HPLC column and SDS-PAGE (15%) of
fragments resulting from chymotryptic cleavage of SPLA2. (A)
An aliquot of the incubation mixture (0.1 mg in 0.1 ml) was applied
to a HPLC column Bio-sil SEC-125 (300 mm × 7.8 mm) equilibrated
in 0.1 M phosphate buffer pH 6.8 containing 0.15 M NaCl, elution
was performed at room temperature within 20 min with the same
buffer at a flow rate of 1 ml/min. Molecular mass markers were
used to estimate the molecular masses of eluted proteins. The
effluent was monitored at 280 nm. AU: arbitrary units. (B) SDS-PAGE
(15%) of the active fraction eluted from HPLC filtration. The gel was
stained with Comassie blue to reveal proteins.
Table 4 Apparent kinetic parameters of SPLA2, 12 kDa SPLA2 and DrPLA2
Vmax (U/mg) Km (mM) Kcat (s
-1)K cat/Km (mM
-1 s
-1)
PE PC PS PE PC PS PE PC PS PE PC PS
SPLA2 2850 ±
200
750 ±
50
290 ±
15
13 ±
0.7
17.33 ±
0.5
20 ±
1.3
669 ± 5.2 187 ±
2.65
68 ± 2.7 51.5 ± 3.7 11.5 ±
0.5
3.4 ± 0.8
12 kDa
SPLA2
2730 ±
150
700 ±
80
300 ±
17
13.8 ±
1
16.5 ± 0.9 22 ±
0.7
640.8 ± 7 146.3 ±
3.8
70.42 ±
3.3
47.4 ± 2.2 9.96 ±
0.3
3.2 ± 0.3
DrPLA2 2300 ±
120
600 ±
45
190 ±
12
16 ±
1.2
22 ± 0.9 28 ±
1.5
539.9 ±
10
140 ± 2.7 44.6 ± 1.9 33.74 ±
2.8
6.36 ±
0.7
2.03 ±
0.1
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decreased substantially at the zwitterionic interface possi-
bly due to the uncoupling between calcium binding and
substrate (inhibitor) binding [34].
4. Conclusion
Marine and mammal pancreatic PLA2 share a high
amino-acid sequence homology. However; the absence
of cross-immunoreactivity between DrPLA2, taken as
mammal model, and anti-SPLA2 serum strengthens the
idea that SPLA2 could be structurally different from
mammalian pancreatic PLA2. Further investigations are
needed to better establish the structure-function rela-
tionship of this class of enzyme and to identify key resi-
dues involved in substrate recognition responsible for
biochemical differences between the classes of PLA2.
Acknowledgements
The authors extend their appreciation to the Deanship of Scientific Research
at King Saud University for funding the work through the research group
project No: RGP-VPP-070.
Author details
1Biochemistry Department, Science College, King Saud University, P.O box
22452, Zip code 11495, Riyadh, Saudi Arabia.
2Laboratoire des
biotechnologies végétales appliquées à l’amélioration des cultures, Faculty of
Science of Sfax, Sfax University, 3038 Sfax, Tunisia.
Authors’ contributions
ABB: designed the study and drafted the manuscript.
HM: helped to draft the manuscript and participated in the design of the
study.
All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 18 May 2011 Accepted: 26 July 2011 Published: 26 July 2011
References
1. Kudo I, Murakami M: Phospholipase A2 enzymes. Prostaglandins Other
Lipid Mediat 2002, 68-69:3-58.
2. Burke JE, Dennis EA: Phospholipase A2 structure/function, mechanism,
and signaling. J Lipid Research 2009, 50:S237-S242.
3. Six DA, Dennis EA: The expanding superfamily of phospholipase A2
enzymes: classification and characterization. Biochim Biophys Acta 2000,
1488:1-19.
4. Rouault M, Bollinger JG, Lazdunski M, Gelb MH, Lambeau G: Novel
mammalian group XII secreted phospholipase A2 lacking enzymatic
activity. Biochemistry 2003, 42:11494-11503.
5. de Haas GH, Postema NM, Nieuwenhuizen W, van Deenen LLM:
Purification and properties of an anionic zymogen of phospholipase A2
from porcine pancreas. Biochim Biophys Acta 1968, 159:118-129.
6. Stoll U: The analysis of phospholipids from cardiac membranes by
phospholipase A. Fett/Lipid 1996, 98:26-30.
7. Yoshinori M: Structural and Functional Changes of Hen’s Egg Yolk Low-
Density Lipoproteins with Phospholipase A2. J Agric Food Chem 1997,
45:4558-4563.
8. Aoi N: Soy lysolecithin. Yukagaku J 1990, 39:10-15.
9. Rana RL, Sarath G, Stanley DW: digestive phospholipase A2 in midguts of
tobacco hornworms, Manduca sexta L. J Insect Physiol 1998, 44:297-303.
10. Audley MA, Shetty KJ, Kinsella JE: Isolation and properties of
phospholipase A from pollock muscle. J Food Sci 1978, 43:771-1775.
11. Neas NP, Hazel JR: Partial purification and kinetic characterization of the
microsomal phospholipase A2 from thermally acclimated rainbow trout
(Salmo gairdneri). J Comp Physiol B 1985, 155:461-469.
12. Aaen B, Jessen F, Jensen B: Partial purification and characterization of a
cellular acidic phospholipase A2 from cod (Gadus morhua). Comp
Biochem Physiol B 1995, 110:547-554.
13. Zambonino Infante JL, Cahu CL: High dietary lipid levels enhance
digestive tract maturation and improve Dicentrarchus labrax larval
development. J Nutr 1999, 129:1195-1200.
14. Cherif S, Ben Bacha A, Ben Ali Y, Horchani H, Rekik W, Gargouri Y: Crab
digestive phospholipase: a new invertebrate member. Bioresour Technol
2010, 101:366-71.
15. Pattus F, Slotboom AJ, de Haas GH: Regulation of Phospholipase A2
Activity by the Lipid-Water Interface: a Monolayer Approach. Biochemistry
1979, 18:2703-2707.
16. Zarai Z, Ben Bacha A, Horchani H, Bezzine S, Gargouri Y, Mejdoub H: A
novel marine hepatopancreatic phospholipase A2 with digestive and
toxic activities. Archives of Biochemistry and Biophysics 2010, 494:121-129.
17. Bacha A, Karray A, Bouchaala E, Gargouri Y, Ben Ali Y: Purification and
biochemical characterization of pancreatic phospholipase A2 from the
common stingray Dasyatis pastinaca. Lipids in Health and Disease 2011,
10:32.
18. Ben Bacha A, Gargouri Y, Bezzine S, Mejdoub H: Purification and
biochemical characterization of phospholipase A2 from dromedary
pancreas. Biochim Biophys Acta 2006, 1760:1202.
19. Bradford MM: A rapid and sensitive method for the quantification of
microgram quantities of proteins utilizing the principle of protein-dye
binding. Anal Biochem 1976, 72:248-254.
20. Abousalham A, Verger R: Egg yolk lipoproteins as substrates for lipases.
Biochim Biophys Acta 2000, 1485:56-62.
21. Laemmli UK: Cleavage of structural protein during the assembly of the
head of bacteriophage T4. Nature 1970, 227:680-685.
22. Bergman H, Jörnvall T: Electroblotting of individual polypeptides from
SDS/polyacrylamide gels for direct sequence analysis. Eur J Biochem 1987,
169:912.
23. Hewick RM, Hunkapiller MW, Hood LE: A gaz-liquid solid phase peptide
and protein sequenator. J Biol Chem 1981, 256:7990-7997.
24. ISMEN A: Age, Growth, Reproduction and Food of Common Stingray
(Dasyatis pastinaca L., 1758) in Iskenderun Bay, the Eastern
Mediterranean. Fisheries Research 2003, 60:169-176.
25. Scott DL, Otwinowski Z, Gelb MH, Sigler PB: Crystal Structure of Bee-
Venom Phospholipase A2 in a Complex with a Transition-State
Analogue. Science 1990, 250:1563-1566.
26. Yu BZ, Berg OG, Jain MK: The divalent cation is obligatory for the binding
of ligands to the catalytic site of secreted phospholipase A2. Biochemistry
1993, 32:6485-6492.
0
50
100
150
200
250
300
0 5 10 15 20 25
F
r
e
e
 
F
a
t
t
y
 
a
c
i
d
 
(
μ
m
o
l
)
Time (min)
Figure 5 Kinetics of hydrolysis of PC emulsion by native SPLA2
(12 U), 12 kDa SPLA2 (12 U) or by DrPLA2 (12 U). PLA2 activity
was followed at pH 8.5 and 40°C in the presence of 4 mM NaTDC
and 8 mM CaCl2. Each data point represents an average of at least
two independent experiments, each in duplicate.
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